Embryo-Fetal Developmental Toxicokinetic Study of CBX129801, a Bio-active C-peptide for Potential Replacement Therapy in Type 1 Diabetic Nephropathy, in Rats and Rabbits After Subcutaneous Injections


To evaluate the maternal toxicokinetics and fetal exposures of CBX129801 in studies which assessed the developmental toxicity, after subcutaneous injection for 4 doses to pregnant female rats and rabbits.